BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hsu PI, Lo GH, Lo CC, Lin CK, Chan HH, Wu CJ, Shie CB, Tsai PM, Wu DC, Wang WM, Lai KH. Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers. World J Gastroenterol 2004; 10(24): 3666-3669 [PMID: 15534928 DOI: 10.3748/wjg.v10.i24.3666]
URL: https://www.wjgnet.com/1007-9327/full/v10/i24/3666.htm
Number Citing Articles
1
Kenneth R DeVault. Pantoprazole: a proton pump inhibitor with oral and intravenous formulationsExpert Review of Gastroenterology & Hepatology 2007; 1(2): 197 doi: 10.1586/17474124.1.2.197
2
Grigoris I. Leontiadis, Virender K. Sharma, Colin W. Howden. Proton Pump Inhibitor Therapy for Peptic Ulcer Bleeding: Cochrane Collaboration Meta-analysis of Randomized Controlled TrialsMayo Clinic Proceedings 2007; 82(3): 286 doi: 10.1016/S0025-6196(11)61024-0
3
C. VAN RENSBURG, A. N. BARKUN, I. RACZ, R. FEDORAK, P. C. BORNMAN, C. BEGLINGER, J. BALANZÓ, J. DEVIÈRE, L. KUPCINSKAS, R. LUEHMANN, H. DOERFLER, S. SCHÄFER‐PREUSS. Clinical trial: intravenous pantoprazole vs. ranitidine for the prevention of peptic ulcer rebleeding: a multicentre, multinational, randomized trialAlimentary Pharmacology & Therapeutics 2009; 29(5): 497 doi: 10.1111/j.1365-2036.2008.03904.x
4
Grigoris I. Leontiadis, Virender K. Sharma, Colin W. Howden. Proton Pump Inhibitor Therapy for Peptic Ulcer Bleeding: Cochrane Collaboration Meta-analysis of Randomized Controlled TrialsMayo Clinic Proceedings 2007; 82(3): 286 doi: 10.4065/82.3.286
5
Donna Chui, Flora Young, Aaron M. Tejani, Edward C. Dillon. Impact of Academic Detailing on Proton Pump Inhibitor Prescribing Behaviour in a Community HospitalCanadian Pharmacists Journal / Revue des Pharmaciens du Canada 2011; 144(2): 66 doi: 10.3821/1913-701X-144.2.66
6
M. SIMON‐RUDLER, J. MASSARD, B. BERNARD‐CHABERT, V. DI MARTINO, V. RATZIU, T. POYNARD, D. THABUT. Continuous infusion of high‐dose omeprazole is more effective than standard‐dose omeprazole in patients with high‐risk peptic ulcer bleeding: a retrospective studyAlimentary Pharmacology & Therapeutics 2007; 25(8): 949 doi: 10.1111/j.1365-2036.2007.03286.x
7
Javier P. Gisbert. Tratamiento farmacológico de la hemorragia digestiva por úlcera pépticaMedicina Clínica 2006; 127(2): 66 doi: 10.1157/13089992
8
K. Herrlinger. Einteilung und Management der oberen gastrointestinalen BlutungDer Internist 2010; 51(9): 1145 doi: 10.1007/s00108-010-2590-9
9
Kevin A. Ghassemi, Thomas O. G. Kovacs, Dennis M. Jensen. Gastric acid inhibition in the treatment of peptic ulcer hemorrhageCurrent Gastroenterology Reports 2009; 11(6): 462 doi: 10.1007/s11894-009-0071-x
10
Thomas O. G. Kovacs. Management of upper gastrointestinal bleedingCurrent Gastroenterology Reports 2008; 10(6): 535 doi: 10.1007/s11894-008-0099-3
11
Yen-I. Chen, Yidan Lu, Hisham Aldahab, Alan Barkun. GI Endoscopic Emergencies2016; : 33 doi: 10.1007/978-1-4939-3085-2_3
12
V. K. Vadgama, Y. A. Patel, T. K. Patel, C. B. Tripathi. Pharmacodynamic interaction between pantoprazole and vecuronium at neuromuscular junctionAutonomic and Autacoid Pharmacology 2011; 31(1-2): 31 doi: 10.1111/j.1474-8673.2011.00463.x
13
Panagiotis Tsibouris, Elias Zintzaras, Christos Lappas, Maria Moussia, George Tsianos, Theodoros Galeas, Spyros Potamianos. High-Dose Pantoprazole Continuous Infusion Is Superior to Somatostatin After Endoscopic Hemostasis in Patients With Peptic Ulcer BleedingThe American Journal of Gastroenterology 2007; 102(6): 1192 doi: 10.1111/j.1572-0241.2007.01120.x
14
Thomas O G Kovacs, Dennis M Jensen. The Short-Term Medical Management of Non-Variceal Upper Gastrointestinal BleedingDrugs 2008; 68(15): 2105 doi: 10.2165/00003495-200868150-00003
15
Loren Laine, Kenneth R. McQuaid. Endoscopic Therapy for Bleeding Ulcers: An Evidence-Based Approach Based on Meta-Analyses of Randomized Controlled TrialsClinical Gastroenterology and Hepatology 2009; 7(1): 33 doi: 10.1016/j.cgh.2008.08.016
16
Antonio Garrido, María Isabel Iborra, Esteban Saperas, Mónica de Sousa. Prevalencia de nueva hemorragia por úlcera péptica en pacientes tratados con inhibidores de la bomba de protones por vía intravenosaMedicina Clínica 2010; 134(13): 577 doi: 10.1016/j.medcli.2009.11.038
17
Keith M. Olsen. Use of acid-suppression therapy for treatment of non-variceal upper gastrointestinal bleedingAmerican Journal of Health-System Pharmacy 2005; 62(10_Supplement_2): S18 doi: 10.1093/ajhp/62.10_Supplement_2.S18
18
Ying-Shi Zhang, Qing Li, Bo-Sai He, Ran Liu, Zuo-Jing Li. Proton pump inhibitors therapy <italic>vs</italic> H<sub>2</sub> receptor antagonists therapy for upper gastrointestinal bleeding after endoscopy: A meta-analysisWorld Journal of Gastroenterology 2015; 21(20): 6341-6351 doi: 10.3748/wjg.v21.i20.6341
19
Dennis M Jensen, Samuel C Pace, Elaine Soffer, Gail M Comer. Continuous Infusion of Pantoprazole versus Ranitidine for Prevention of Ulcer Rebleeding: A U.S. Multicenter Randomized, Double-Blind StudyThe American Journal of Gastroenterology 2006; 101(9): 1991 doi: 10.1111/j.1572-0241.2006.00773.x
20
Hisham AL Dhahab, Alan Barkun. The Acute Management of Nonvariceal Upper Gastrointestinal BleedingUlcers 2012; 2012: 1 doi: 10.1155/2012/361425
21
John W Devlin, Lynda S Welage, Keith M Olsen. Proton Pump Inhibitor Formulary Considerations in the Acutely Ill Part 2: Clinical Efficacy, Safety, and EconomicsAnnals of Pharmacotherapy 2005; 39(11): 1844 doi: 10.1345/aph.1G176
22
Philip E. Donahue. Acute Care Surgery2007; : 450 doi: 10.1007/978-0-387-69012-4_29
23
Kirill Rivkin, Aleksandr Lyakhovetskiy. Treatment of nonvariceal upper gastrointestinal bleedingAmerican Journal of Health-System Pharmacy 2005; 62(11): 1159 doi: 10.1093/ajhp/62.11.1159
24
Hwai-Jeng Lin, Wen-Ching Lo, Yang-Chih Cheng, Chin-Lin Perng. Role of Intravenous Omeprazole in Patients with High-Risk Peptic Ulcer Bleeding After Successful Endoscopic Epinephrine Injection: A Prospective Randomized Comparative TrialThe American Journal of Gastroenterology 2006; 101(3): 500 doi: 10.1111/j.1572-0241.2006.00399.x
25
Iyad Khamaysi, Ian M. Gralnek. THE EFFICACY OF INTRAVENOUS PROTON PUMP INHIBITORS (IV PPI) AFTER ENDOSCOPIC EPINEPHRINE INJECTION IN PATIENTS WITH HIGH-RISK PEPTIC ULCER BLEEDINGEvidence-Based Gastroenterology 2007; 8(1): 1 doi: 10.1097/EBG.0b013e318031dfb6
26
Stephen W Nissen, Keith M Olsen. Selection of Proton Pump Inhibitors for Formulary InclusionDisease Management & Health Outcomes 2007; 15(5): 289 doi: 10.2165/00115677-200715050-00003
27
Eduardo A. Rodriguez, Elie Donath, Akbar K. Waljee, Daniel A. Sussman. Value of Oral Proton Pump Inhibitors in Acute, Nonvariceal Upper Gastrointestinal BleedingJournal of Clinical Gastroenterology 2017; 51(8): 707 doi: 10.1097/MCG.0000000000000625
28
Mohamed H. Emara, Ehab M. Darwiesh, Ahmed S. Bihery, Tarik I. Zaher. Endoscopic injection of autologous blood versus diluted epinephrine for control of actively bleeding gastroduodenal ulcersEuropean Journal of Gastroenterology & Hepatology 2014; 26(11): 1267 doi: 10.1097/MEG.0000000000000180
29
Christo J. Van Rensburg, Susan Cheer. Pantoprazole for the Treatment of Peptic Ulcer Bleeding and Prevention of RebleedingClinical Medicine Insights: Gastroenterology 2012; 5: CGast.S9893 doi: 10.4137/CGast.S9893
30
Insung Kim, Yoon-Seon Lee, Byuk Sung Koh, Won Kim, Kyoung Soo Lim. Does Adding Somatostatin to Proton Pump Inhibitor Improve the Outcome of Peptic Ulcer Bleeding?The Korean Journal of Critical Care Medicine 2008; 23(2): 75 doi: 10.4266/kjccm.2008.23.2.75
31
Grigorios I. Leontiadis, Colin W. Howden. The Role of Proton Pump Inhibitors in the Management of Upper Gastrointestinal BleedingGastroenterology Clinics of North America 2009; 38(2): 199 doi: 10.1016/j.gtc.2009.03.008